FDA rejects Indivior's nasal spray for opioid overdose

November 24, 2015 5:48 PM

24 0

Nov 24 Indivior Plc said on Tuesday the U.S. Food and Drug Administration rejected its nasal spray for the emergency treatment of opioid overdose.

These sprays contain naloxone, a drug that has been used to treat opioid overdose for nearly 45 years in injectable forms.

Also read: FDA approves Gilead's drug for chronic hep C patients

Read more

To category page